Skip to content

The Effect of Baduanjin Exercise on Health Benefits for Breast Cancer Survivors in China: A Randomized Controlled Trial

The Effect of Baduanjin Exercise on Health Benefits for Breast Cancer Survivors in China: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018171
Enrollment
Unknown
Registered
2018-09-03
Start date
2017-10-01
Completion date
Unknown
Last updated
2018-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Sponsors

Tianjin Medical University Cancer Institute & Hospital, Breast Cancer Rehabilitation Center
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
36 Years to 72 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 years old; 2. stage I–III breast cancer; 3. completion of active treatment (e.g., surgery, chemotherapy, and/or radiation) within the past 2 years; 4. local residence who is convenient to come to the hospital; 5. without complication of cardiac, neural, muscle and/or joint related physical disease; 6. without cognitive dysfunction and/or communication disorder.

Exclusion criteria

Exclusion criteria: 1. combined with other malignant tumors; 2. with a history of serious mental illness (i.e., schizophrenia, other psychotic disorders, bipolar disorders, major depressive disorder); 3. Patients who could not undertake physical exercise (who had underlying cardiac, neural, muscle and/or joint diseases).

Design outcomes

Primary

MeasureTime frame
Body mass index (BMI);Target heart rate;Lung capacity;Circumference of ill arm;Shoulder mobility of ill arm;Step test index;Anxiety;Depression;Quality of life;

Countries

China

Contacts

Public ContactQiang Wan Min

Tianjin Medical University Cancer Institute & Hospital, Breast Cancer Rehabilitation Center

52133433@qq.com+86 18622221009

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026